Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse

Methamphetamine (METH) substance abuse disorders have major impact on society, yet no medications have proven successful at preventing METH relapse or cravings. Anti-METH monoclonal antibodies can reduce METH brain concentrations; however, this therapy has limitations, including the need for repeate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Hay, Charles E., Gonzalez, Guillermo A., Ewing, Laura E., Reichard, E. Elizabeth, Hambuchen, Michael D., Nanaware-Kharade, Nisha, Alam, Sinthia, Bolden, Chris T., Owens, S. Michael, Margaritis, Paris, Peterson, Eric C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6025879/
https://ncbi.nlm.nih.gov/pubmed/29958300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0200060
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi